Brussels is set to almost triple its orders of Moderna’s coronavirus vaccine as part of an EU push to respond to the emergence of new variants and the possible need for booster shots.

The European Commission and Moderna on Wednesday announced a deal for a further 150m doses of the US pharmaceutical company’s jab this year, and an option for 150m more next year. Next year’s order could be of a vaccine tailored to a new variant, if necessary, one person familiar with the matter said. 

The agreement, first reported by the Financial Times, would add to Brussels’ agreement last year to buy 160m Moderna shots. It is part of a wider effort to tackle criticism of the EU’s sluggish vaccine rollout and prepare for the possible evolution of the disease as mutant strains appear. 


Source: Financial Times